Soluble adhesion molecules in renal transplantation

Area of Science:

• Nephrology
• Immunology
• Transplant Surgery

Background:

• Kidney transplant recipients face risks of acute rejection and complications like CsA toxicity and ATN.
• Monitoring biomarkers is crucial for early detection and management of post-transplant complications.
• Adhesion molecules and cytokines play roles in the inflammatory processes following transplantation.

Purpose of the Study:

• To investigate the diagnostic and predictive value of serum levels of sICAM-1, sVCAM-1, and TNF in kidney transplant recipients.
• To differentiate between stable graft function, acute rejection, CsA toxicity, ATN, and CMV disease based on these biomarkers.

Main Methods:

• Serum levels of sICAM-1, sVCAM-1, and TNF were measured in 50 kidney transplant recipients.
• Patients were categorized into groups based on graft function and post-transplant complications.
• Statistical analysis was performed to compare biomarker levels across different patient groups.

Main Results:

• All patients initially showed elevated sICAM-1 levels post-transplant.
• Patients with stable graft function exhibited reduced sICAM-1 levels.
• Significantly increased sICAM-1 levels were detected 3-4 days before acute allograft rejection diagnosis (p < 0.001).
• sVCAM-1 levels were elevated in acute rejection and CsA toxicity but lacked statistical significance compared to ATN or stable groups.
• No significant differences in TNF levels were observed between groups.

Conclusions:

• Quantitative determination of serum sICAM-1 holds predictive clinical value for acute renal allograft rejection.
• sICAM-1 may serve as an early warning marker for acute rejection in kidney transplant patients.
• Further research could explore sICAM-1's role in monitoring other transplant-related conditions.